ليست عنوان مقالات لاتين Drug abuse toll uncovered in Kenya Dry sliding wear behavior of Al-based composites fabricated by exothermic dispersion reaction in an Al–ZrO2–C system

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Drug abuse toll uncovered in Kenya

2

Drug abuse, HIV/AIDS and stigmatisation in a Dai community in Yunnan, China

3

Drug abuse: A significant variable in schizophrenia research

4

Drug Action at the 5-HT(1A) Receptor in Vivo: Autoreceptor and Postsynaptic Receptor Occupancy Examined with PET and [carbon:yl-11C]WAY-100635

5

Drug Action of Ritodrine on the Sarcoplasmic-Reticulum Ca2+-ATPase from Skeletal Muscle

6

Drug actions in preeclampsia: Aspirin, but not magnesium chloride or dihydralazine, differentially inhibits cultured human trophoblast release of thromboxane and prostacyclin without affecting angiotensin II, endothelin-1, or leukotriene B4 secretion

7

DRUG ADDICTION AND HEPATITIS B AND C IN PAKISTAN

8

Drug addiction and HIV infection on rise in Tajikistan

9

Drug addiction and the economic rationalization of gun control

10

Drug addiction and the economic rationalization of gun control

11

Drug Addiction and Vitamin D Supplementation: How to Address a Health Concern in Methadone Treatment?

12

Drug addiction as drive satisfaction ("antidrive") dysfunction

13

Drug Addiction as Risk for Suicide Attempts

14

Drug addiction in Gaza and the illicit trafficking of tramadol

15

Drug addiction: the neurobiology of disrupted self-control

16

Drug administration to poultry

17

Drug adverse events and drop-out risk: A clinical case

18

Drug advertisements and prescribing

19

Drug advertisements and prescribing

20

Drug advertisements in less-developed countries

21

Drug advertisements in medical journals

22

Drug advertisements that go straight to the hippocampus

23

Drug advertising in medical journals

24

Drug advertising in medical journals

25

Drug advertising in medical journals

26

Drug advertising in medical journals

27

Drug advertising in medical journals

28

Drug advertising in medical journals

29

Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis

30

Drug allergic reactions and distress vulnerability

31

Drug allergies among patients with borderline personality symptomatology

32

33

Drug allergy transmitted by passionate kissing

34

Drug and alcohol abuse: A clinical guide to diagnosis and treatment (4th ed.) : Marc A. Schuckit. New York: Plenum Press, 1995. 371 pp. (xviii), $34.50

35

Drug and Alcohol Education for Consumer Workers and Caregivers: A Pilot Project Assessing Attitudes Toward Persons With Mental Illness and Problematic Substance Use

36

Drug and alcohol use among drivers admitted to a Level-1 trauma center

37

Drug and Alcohol Use in Emergency Medicine Residency: An Impaired Residentʹs Perspective

38

Drug and alcohol use in Spain: consumption habits, attitudes and opinions

39

Drug and cell encapsulation: Alternative delivery options for the treatment of malignant brain tumors

40

Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses

41

Drug and DNA delivery to mitochondria

42

Drug and DNA delivery to mitochondria

43

Drug and ECT treatment of depression in the elderly, 1996–2001: a literature review

44

Drug and gene delivery to mucosal tissues: the mucus barrier

45

Drug and herbal medicine-induced nephrotoxicity in children; review of the mechanisms

46

Drug Attitude Inventory in Patients with Bipolar Disorder: Psychometric Properties

47

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

48

DRUG BIT CUTTING TRACE IMAGE COLOURS AND CUTTING FORCE FLUCTUATION RELATION

49

Drug bulletins: independent information for global use

50

Drug Calculation Cards and Medication Errors in the Neonatal Intensive Care Units

51

Drug calculation skills — Are we running scared?

52

Drug Calculations for Nurses: Robert Lapham, Heather Agar, Arnold, 1995, 0-340604-79-4, 250 pages, Price £5.99

53

Drug choices in the treatment of atrial fibrillation

54

Drug classification systems: Applications and characteristics

55

Drug Clearance and Arterial Uptake After Local Perivascular Delivery to the Rat Carotid Artery

56

Drug combinations best in acute asthma attacks

57

Drug combinations for HD tested in Drosophila

58

Drug combinations for malaria: time to ACT?

59

Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination

60

Drug companies can broadcast across Europe

61

Drug companies caught again for fixing worldwide vitamin prices

62

Drug company sued over research trial in Nigeria

63

Drug company trials come under increasing scrutiny

64

Drug comparison and categorizing regarded with human serum albumin

65

Drug complications poorly recorded in medical charts

66

Drug courts for DWI offenders? The effectiveness of two hybrid drug courts on DWI offenders

67

Drug courts: A bridge between criminal justice and health services

68

Drug Craving Terminology among Opiate Dependents;

69

Drug Cravings and Its Relationship With Family Communication Patterns and Resiliency Through the Mediatory Role of Difficulty in Cognitive Emotion Regulation

70

Drug crops threaten Colombian birds

71

72

Drug delivery and tissue engineering applications of biocompatible pectin–chitin/nano CaCO3 composite scaffolds

73

Drug delivery applications of supercritical fluid technology

74

Drug delivery design for intravenous route with integrated physicochemistry, pharmacokinetics and pharmacodynamics: Illustration with the case of taxane therapeutics

75

Drug delivery devices based on macroporous silica spheres

76

Drug Delivery for Brains and Central Nervous System

77

Drug delivery for in vitro fertilization: Rationale, current strategies and challenges

78

Drug delivery from gold and titanium surfaces using self-assembled monolayers

79

Drug delivery from hydrophobic-modified mesoporous silicas: Control via modification level and site-selective modification

80

Drug delivery in degenerative joint disease

81

Drug delivery in degenerative joint disease: Where we are and where to go?

82

Drug delivery investigations of quaternised poly(propylene imine) dendrimer using nimesulide as a model drug

83

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

84

Drug delivery property, bactericidal property and cytocompatibility of magnetic mesoporous bioactive glass

85

Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice

86

Drug delivery strategies in the therapy of inflammatory bowel disease

87

Drug delivery strategies to treat age-related macular degeneration

88

Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities

89

Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers

90

Drug delivery systems : Vascant V. Ranade and Mannfred A. Hollinger CRC Press, Boca Raton, Florida, 1995, 364 pp. Dr Lisa Brannon-Peppas

91

Drug delivery systems using sandwich configurations of electrospun poly(lactic acid) nanofiber membranes and ibuprofen

92

Drug delivery systems: polymers and drugs monitored by capillary electromigration methods

93

Drug delivery therapies I: General trends and its importance on bone tissue engineering applications

94

Drug delivery therapies II.: Strategies for delivering bone regenerating factors

95

Drug Delivery through Nose: A Noninvasive Technique for Brain Targeting

96

Drug delivery to mitochondria: the key to mitochondrial medicine

97

Drug delivery to mitochondria: the key to mitochondrial medicine

98

Drug delivery to peroxisomes: Employing unique trafficking mechanisms to target protein therapeutics

99

Drug delivery to solid tumors by elastin-like polypeptides

100

Drug delivery to the brain in Alzheimerʹs disease: Consideration of the blood–brain barrier

101

Drug delivery to the brain-just a sniff away

102

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

103

Drug delivery to the posterior segments of the eye

104

Drug delivery vehicles on a nano-engineering perspective

105

Drug Demand Function for Iranian Urban Households Based on Householdsʹ Budget

106

Drug Dependency and Womenʹs Health

107

Drug dependent parents: Childcare responsibilities, involvement with treatment services, and treatment outcomes

108

Drug deregulation in Japan likely by 1998

109

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

110

Drug design and synthesis of ε opioid receptor agonist: 17-(cyclopropylmethyl)-4,5α-epoxy-3,6β-dihydroxy-6,14-endoethenomorphinan-7α-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative ε opioid receptor Original Resea

111

Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease Original Research Article

112

Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist

113

Drug design; HIV; Organosilane; Protease inhibitor; Silanediol

114

Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner Original Research Article

115

Drug detection by tandem mass spectrometry on the basis of adduct formation

116

Drug development and clinical research in the UK

117

Drug development for neglected diseases

118

Drug development for neglected diseases: a deficient market and a public-health policy failure

119

Drug development for tuberculosis: the missing ingredient

120

Drug development output: what proportion for tropical diseases?

121

Drug diffusion from disperse systems with a hydrophobically modified polysaccharide: Enhancer® vs Franz cells

122

Drug diffusion in hydrophobically modified N,N-dimethylacrylamide hydrogels

123

Drug Diffusion Inside a Non-Degradable Hydrogel Microneedle

124

DRUG DISCONTINUATION IN EPILEPTIC CHILDREN: PREDICTIVE VALUE OF THE EEG

125

Drug Discovery Acceleration Using Digital Microfluidic Biochip Architecture and Computer-aided-design Flow

126

Drug discovery and chemokine receptor antagonists: eppur si muove!

127

Drug Discovery and Delivery in the 21st Century

128

Drug Discovery and Evaluation

129

Drug discovery and sea hares: bigger is better

130

Drug Discovery in the Clouds

131

Drug discovery in the new millennium: the pivotal role of biotechnology

132

Drug discovery in the wake of genomics

133

Drug discovery of the future: the implications of the human genome project

134

Drug discovery through stem cell-based organoid models

135

Drug dispensing systems in Gaza hospitals: a comparative study

136

Drug disposition in obesity and protein-energy malnutrition

137

Drug distribution within poly(ɛ-caprolactone) microspheres and in vitro release

138

Drug dosing errors in simulated paediatric emergencies – Comprehensive dosing guides outperform length-based tapes with precalculated drug doses

139

Drug efficacy of praziquantel and albendazole in school children in Mwea Division, Central Province, Kenya

140

Drug efflux transporters in the CNS

141

Drug elimination in chronic liver diseases

142

Drug eluting stent

143

Drug ELuting Stent Complications

144

Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes

145

Drug Eluting Stent Restenosis

146

Drug eluting stents

147

Drug Eluting Stents Comparisons

148

Drug Eluting Stents I

149

Drug Eluting Stents II

150

Drug Eluting Stents in Diabetic Patients

151

Drug eluting stents may not be the answer for myocardial bridges

152

Drug eluting stents: Comparative results

153

Drug eluting stents: Current status and new developments

154

Drug eluting stents: In stent restenosis

155

Drug eluting stents: Long term results

156

Drug eradicates Chagasʹ parasite in mice

157

Drug evaluations using a novel microphysiometer based on cell-based biosensors

158

Drug excretion in breast milk: mechanisms, models and drug delivery implications for the infant

159

Drug excretion into breast milk—Overview

160

Drug exposed infants in the social welfare system and Juvenile Court

161

Drug firm buys up chain of US cancer clinics

162

Drug firm compensates patients for suspected hepatitis B vaccine failure

163

Drug firm support of American Medical Association ethics effort draws fire

164

Drug firm withdraws statin from the market

165

Drug firms lose patent rights lawsuit against South Africaʹs government

166

Drug firmsʹ representatives express concern over WHOʹs AIDS drug list

167

Drug firms take South Africaʹs government to court

168

Drug firms under fire over anti-competition in USA

169

Drug for impotence breaks prescription records

170

Drug Guru: A computer software program for drug design using medicinal chemistry rules Original Research Article

171

Drug Hypersensitivity Reactions in Hospital-Admitted Children: A Single Center Study in Southern Iran

172

drug hypersensitivity reactions in hospital-admitted children: a single center study in southern iran

173

Drug identification performance on the basis of observable signs and symptoms

174

Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants

175

Drug immunosuppression therapy for adult heart transplantation. Part 2: clinical applications and results

176

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase Original Research Article

177

DRUG INDUCED (CALCIUM CHANNEL BLOCKERS) GINGIVAL HYPERPLASIA

178

Drug Induced Autoimmune Hepatitis by Amoxicillin- Clavulanate

179

Drug induced blistering and the plastic surgeon: a case of amitriptyline induced skin necrosis

180

Drug Induced Ectropion: a Systematic Review

181

Drug Induced Gingival Overgrowth and Its Management

182

Drug induced hepatitis among Iranian patients suffering from tuberculosis

183

Drug Induced Sialorrhea and Microfluidic-Chip-Electrophoretic Analysis of Engorged Adult Female Tick Saliva of Haemaphysalis longicornis (Acari: Ixodidae)

184

Drug Induced Sleep Endoscopy in Obstructive Sleep Apnea

185

Drug industry lobbies against European research-data directive

186

Drug Information Resources at Private Community Pharmacies in Kuwait

187

Drug Injecting and HIV Infection: Global Dimensions and Local Responses; Edited by Gerry Stimson, Don C. Des Jarlais and Andrew Ball. UCL Press Ltd, London, 1998. 294 pp, £14.95 (paper).

188

Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran

189

Drug injection cessation among HIV-infected injecting drug users

190

Drug interaction between rifampicin and sirolimus in transplant patients

191

Drug Interaction of Glycyrrhiza glabra L. with Chemical Drugs: A mini Review study

192

Drug interaction of St Johnʹs wort with ciclosporin

193

Drug Interactions Among Hospitalized Patients in Intensive Care Units and Infectious Ward, Hamadan, Iran

194

Drug interactions and anti-infective therapies

195

Drug Interactions between Psychoactive Agents and Antiepileptic Agents

196

Drug Interactions Casebook: The Cytochrome P450 System and Beyond, 2nd ed.: By Neil B. Sandson. Washington, DC, American Psychiatric Press, 2003 ($35.50, paperback ed.), 334 pp

197

Drug interactions in cancer patients: A hidden risk?

198

Drug Interactions in Iranian Veterans With Chronic Spinal Cord Injury - A Descriptive Study

199

Drug Interactions of Green Tea

200

Drug Interactions of Metformin Involving Drug Transporter Proteins

201

Drug Interactions of Psychiatric and COVID-19 Medications

202

Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding

203

Drug interactions with potential rubber closure extractables: Identification of thiol–disulfide exchange reaction products of captopril and thiurams

204

Drug interactions with the taxanes: clinical implications

205

Drug interactions with zileuton

206

Drug interactions with zileuton

207

Drug interactions—fact or fiction?

208

Drug intervention trials in sepsis

209

Drug intervention trials in sepsis: divergent results

210

Drug kinetics and drug resistance in optimal chemotherapy

211

Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

212

Drug loaded poly[Lac(Glc-Leu)] microparticles: Formulation and release characteristics

213

Drug loaded thermoresponsive and cytocompatible chitosan based hydrogel as a potential wound dressing

214

Drug loading onto ion-exchange microspheres: Modeling study and experimental verification

215

Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes Original Research Article

216

Drug Management in Crisis and Disaster in Selected Countries and Iran

217

DRUG MANAGEMENT REVIEWS IN DISTRICT DRUG MANAGEMENT UNIT AND GENERAL HOSPITAL

218

Drug may avoid need for parathyroidectomy

219

Drug Mediated S-glutathionylation of PDI leads to alterations in secondary structure, inhibition of isomerase activity, and triggers ER-stress induced apoptosis

220

Drug metabolism and drug interactions in the elderly

221

Drug metabolism enzymes in a steatotic model of rat treated with a high fat diet and a low dose of streptozotocin

222

Drug name confusion: evaluating the effectiveness of capital (“Tall Man”) letters using eye movement data

223

Drug nanocarrier agents based on starch-g-amino acids

224

Drug Nano-Particles Formation by Supercritical Rapid Expansion Method; Operational Condition Effects Investigation

225

Drug partition chromatography on immobilized porcine intestinal brush border membranes

226

Drug Patents 2001: A Review of Pharmaceutical Patenting, 1995–2001

227

Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films

228

Drug permeation through temperature-sensitive membranes prepared from poly(vinylidene fluoride) with grafted poly(N-isopropylacrylamide) chains

229

Drug policy in China: pharmaceutical distribution in rural areas

230

Drug policy: should the law take a back seat?

231

Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan

232

Drug prescription habits in public and private health facilities in 2 provinces in South Africa

233

Drug Prescription Pattern in a Nigerian Tertiary Hospital

234

Drug prescriptions after acute myocardial infarction: Dosage, compliance, and persistence

235

Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey

236

Drug prevents SIV infection

237

Drug pricing policies in one of the largest drug manufacturing nations in the world: Are affordability and access a cause for concern?( Editorial Jan-Mar 2015 / Vol 4 / Issue 1)

238

Drug problem recognition among african american drug-using arrestees

239

Drug Properties, Chemical Reactivity and Docking Binding Energy of Cinnamon with Estrogen, Testosterone, Progesterone as Potential Drug: Theoretical Investigation

240

Drug quality, a contributor to drug resistance?

241

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Cause Interstitial Nephritis: a case Report and Review of Literatures

242

Drug Rash With Eosinophilia and Systemic Symptoms Syndrome in Infancy: A Report of Two Rare Cases

243

Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification

244

Drug Reaction with Eosinophilia and Systemic Symptom in a Patient with Pneumonia and Hyperthyroidism

245

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Presenting with Primary Diagnosis of Hepatocellular Carcinoma

246

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

247

Drug Reaction With Eosinophilia and Systemic Symptoms Induced by Valproic Acid: A Case Report

248

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin

249

Drug Receptor Identification from Multiple Tissues Using Cellular-Derived mRNA Display Libraries Original Research Article

250

Drug Recognition and Stabilisation of the Parallel-stranded DNA Quadruplex d(TTAGGGT)4 Containing the Human Telomeric Repeat

251

Drug referendum backs Swiss government

252

Drug reimportation: sitting in the middle

253

Drug related deaths in Tehran, Iran: Toxicological, Death and Crime Scene investigations

254

Drug related deaths—causes and numbers

255

Drug Related Hospital Admissions; A Systematic Review of the Recent Literatures

256

Drug release behavior of beads and microgranules of chitosan

257

Drug release behavior of chitosan–montmorillonite nanocomposite hydrogels following electrostimulation

258

Drug Release Characteristics and Tissue Distribution of Rifapentine Polylactic Acid Sustained-Release Microspheres in Rabbits after Paravertebral Implantation

259

Drug release characteristics of phase separation pHEMA sponge materials

260

Drug release from a N-vinylpyrrolidinone/acrylic acid lubricious hydrophilic coating

261

Drug release from a porous ion-exchange membrane in vitro

262

Drug release from a two-layer stent coating considering the viscoelastic property of the arterial wall: A mathematical and numerical study

263

Drug release from calcium and zinc pectinate beads: Impact of dissolution medium composition

264

Drug release from chitosan–alginate complex beads reinforced by a naturally occurring cross-linking agent

265

Drug release from ion-exchange microspheres: Mathematical modeling and experimental verification

266

Drug release from layered double hydroxides and from their polylactic acid (PLA) nanocomposites

267

Drug release from starch-acetate microparticles and films with and without incorporated α-amylase

268

Drug release from α,β-poly(N-2-hydroxyethyl)- -aspartamide-based microparticles

269

Drug release kinetics and biological properties of a novel local drugcarrier system

270

Drug release kinetics from monolayer films of glucose-sensitive microgel

271

Drug release mechanisms of chemically cross-linked albumin microparticles: Effect of the matrix erosion

272

Drug release rate and kinetic investigation of composite polymeric nanofibers

273

Drug Release Studies from Caesalpinia pulcherrima Seed Polysaccharide

274

Drug Release Studies of Naproxen Agglomerates Produced by the Antisolvent Approach in the Presence of Hydroxypropyl Cellulose

275

Drug release through liposome pores

276

Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF Inhibitors Original Research Article

277

Drug Repositioning: A Review

278

Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches

279

Drug Repurposing Is a New Opportunity for Developing Drugsagainst Neuropsychiatric Disorders

280

Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review

281

Drug resistance among acid-fast bacilli

282

Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city

283

Drug resistance and apoptosis-inducing strategies in cancer therapy

284

Drug resistance and influenza pandemics

285

Drug resistance and influenza pandemics

286

Drug resistance and influenza pandemics

287

Drug resistance and influenza pandemics

288

Drug Resistance and Serotyping of Uropathogenic Escherichia coli Among Patients With Urinary Tract Infection in Rasht, Iran

289

Drug resistance and Susceptibility of Mycobacterium tuberculosis identified at University Kebangsaan Malaysia Medical Centre

290

Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review

291

Drug resistance and virulence-associated genes screening in Salmonella enterica isolated from Caspian pony, Iran

292

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

293

Drug resistance gene transfer: Stem cell protection and therapeutic efficacy

294

Drug resistance in cancer, J.H. Goldie, A.J. Goldman. Cambridge University Press, Cambridge (1998)

295

Drug resistance in epilepsy: not futile, but complex?

296

Drug Resistance in Equine Parasites: An Emerging Global Problem

297

Drug resistance in isolated bacteria from milk of sbeep and goats witb subclinical mastitis in Sbabrekord district

298

Drug resistance in malaria: Its population biology and implications for control

299

Drug Resistance in the Clinical Management of HIV – A Special Focus on the Adherence Issues

300

Drug resistance in tuberculosis—a reinfection model

301

Drug resistance models for malaria

302

Drug Resistance of Acinetobacter in Selected Hospitals

303

Drug resistance of isolated strains of Pseudomonas Aeruginosa from burn wound infections to selected antibiotics and disinfectants

304

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS

305

Drug Resistance of Mycobacterium tuberculosis Complex among Newly Diagnosed Tuberculosis Cases in Burkina Faso

306

Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran

307

DRUG RESISTANCE PATTERN AMONG AFB SMEAR POSITIVE RETREATMENT COMPLETED CASES

308

Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran

309

Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis

310

Drug Resistance Pattern of Pseudomonas aeruginosa Isolates Carrying MexAB-OprM Efflux Pump’s Associated Genes in Companion Birds with Respiratory Infection

311

Drug resistance pattern of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients at Isfahan AL Zahra hospital, Iran (2009-2010)

312

Drug Resistance Patterns in HIV Patients with Virologic Failure in Iran

313

Drug resistance patterns in pulmonary tuberculosis

314

Drug resistance profile and subtyping of HIV-1 RT gene in Iranian patients under treatment

315

Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells

316

Drug Resistance versus Spiritual Resistance: A Comparative Analysis from the Perspective of Spiritual Health

317

Drug resistance, plasmids, biotypes and susceptibility to bacteriophages of Salmonella isolated from poultry in Canada

318

Drug Resistance: A Periplasmic Ménage à Trois

319

Drug resistance–virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission

320

Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy

321

Drug resistant Plasmodium falciparum in an area of seasonal transmission

322

Drug resistant tuberculosis in Africa: Current status, gaps and opportunities

323

Drug Resistant Tuberculosis: Gold, Glitter and Hope

324

Drug risk assessment with determining the number of sub-populations under finite mixture normal models

325

Drug Safety Crises Management in Pharmacovigilance

326

Drug Screening versus History in detection of substance use in ED Psychiatric Patients

327

328

Drug sensitivity of trypanosome populations from cattle in a peri-urban dairy production system in Uganda

329

Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda

330

Drug shows potential for treatment of Huntingtonʹs disease

331

Drug shows promise for treatment of Alzheimerʹs disease

332

Drug solubility: how to measure it, how to improve it

333

Drug Stroop performance: Relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample

334

Drug subsidy could help Tanzania tackle malaria

335

Drug Supply Chain Management and Implementation of Health Reform Plan in Teaching Hospital Pharmacies of Ahvaz, Iran

336

DRUG SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE STRAINS ISOLATED IN TEHRAN, IRAN

337

Drug Switching, a Creative Approach to Leukemia Therapy

338

Drug target inference through pathway analysis of genomics data

339

Drug targeting of airway surface liquid: A pharmacological MRI approach

340

Drug targeting to choroidal neovascularization

341

Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems

342

Drug targeting to the kidney

343

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells

344

Drug testing litigation: Trends and outcomes

345

Drug testing sworn law enforcement officers: One agencyʹs experience

346

Drug Therapeutic Failures as a Cause of Admission to an Intensive Care Unit at a University Hospital

347

348

349

Drug therapy and microvolt T-wave alternans testing

350

Drug therapy and microvolt T-wave alternans testing

351

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy

352

Drug therapy for coronary heart disease: the Sheffield table

353

Drug therapy for coronary heart disease: the Sheffield table

354

Drug therapy for coronary heart disease: the Sheffield table

355

Drug therapy for coronary heart disease: the Sheffield table

356

Drug therapy for coronary heart disease: the Sheffield table

357

Drug therapy for coronary heart disease: the Sheffield table

358

Drug Therapy for Hypercholesterolemia in Patients With Cardiovascular Disease: Factors Limiting Achievement of Lipid Goals

359

Drug Therapy for Hypercholesterolemia: Time to End the Double Standard

360

Drug therapy for inflammatory bowel disease in pregnancy and the puerperium

361

Drug therapy for management of obesity

362

Drug therapy for management of obesity

363

Drug Therapy for Small Abdominal Aortic Aneurysm

364

Drug therapy for treatment of obesity

365

Drug therapy for urinary incontinence

366

Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

367

Drug Therapy in Atrial Fibrillation Management: Where Do We Stand in 2010?

368

Drug therapy in paediatric patients

369

Drug therapy in reproductive endocrinology

370

Drug therapy increases long-term survival in pulmonary hypertension patients

371

Drug therapy of diabetes in the elderly

372

Drug therapy versus implantation of a cardiac defibrillator for the treatment of malignant arrhythmias in left ventricular dysfunction

373

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

374

Drug Trafficking and Criminal Justice

375

Drug trajectories among youth undergoing treatment: The influence of psychological problems and delinquency

376

Drug transfer through mucus

377

Drug transfer through mucus

378

Drug transport in corneal epithelium and blood–retina barrier: Emerging role of transporters in ocular pharmacokinetics

379

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

380

Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels

381

Drug transport proteins in the liver

382

Drug treatment behind bars: Prison-based strategies for change : By Kevin E. Early Praeger Publishers (P.O. Box 5007, Westport, Connecticut 06881-5007), 1996, 192 pp., hardcover—$55.00

383

Drug treatment for bleeding oesophageal varices

384

Drug treatment for Crohnʹs disease

385

Drug treatment of bothersome lower urinary tract symptoms after ureteric JJ-stent insertion: A contemporary, comparative, prospective, randomised placebo-controlled study, single-centre experience

386

Drug treatment of delirium: Past, present and future

387

Drug treatment of non-variceal upper gastrointestinal bleeding

388

Drug treatment of obesity

389

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?

390

Drug treatment outcome methodology (1993–1997): Strengths, weaknesses, and a comparison to the alcohol field

391

Drug treatment-related factors of inadequate seizure control

392

Drug treatments for obesity

393

Drug treatments for obesity

394

Drug treatments for obesity

395

Drug treatments for obesity – Authorsʹ reply

396

Drug treatments for obesity: orlistat, sibutramine, and rimonabant

397

Drug treatments of levodopa-induced dyskinesias

398

Drug Use among Residents of Juvenile Correctional Center in Kerman, Iran, and its Relationship with Personality Dimensions and Self-concept

399

Drug use and abuse in sport

400

Drug use and drinking among students in 36 countries

401

Drug Use and High-Risk Sexual Behaviors of Women at a Drop-In Center in Mazandaran Province, Iran, 2014

402

Drug use and HIV/ AIDS in Burma

403

Drug Use and Sex Work Among At-risk Women: A Qualitative Study of Initial Factors

404

Drug use and the severity of a traffic accident

405

Drug use behaviors among asian drug users in san francisco

406

Drug use behaviour of pregnant women in rural India

407

Drug use during pregnancy

408

Drug use during pregnancy

409

Drug use during pregnancy: are risk classifications more dangerous than the drugs?

410

Drug use evaluation of antibiotics prescribed in a Jordanian Hospital outpatient and emergency clinics using WHO prescribing indicators

411

Drug use evaluation of antibiotics prescribed in a Jordanian hospital outpatient and emergency clinics using WHO prescribing indicators

412

Drug Use Evaluation of Crystalline Penicillin in Pediatrics Ward of Dessie Referral Hospital, North East Ethiopia: A Hospital Based Cross Sectional Study

413

Drug Use Evaluation of Human Intravenous Immunoglobulin (IVIG) in a Teaching Hospital in East of Iran

414

Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study

415

Drug use is associated with elevated food consumption in college students

416

Drug Use Pattern Among Elderly People Referred to the Retirement Centers

417

Drug Use Patterns at Major Rock Concert Events

418

Drug usersʹ access to community-based services

419

Drug usersʹ brains to be removed 2 hours after death

420

Drug usersʹ sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management

421

Drug utilisation and self-medication in rural communities in Vietnam

422

Drug utilization and nutrition patterns among children from indigent and emigrant families in Crete, Greece

423

Drug Utilization Evaluation of Agents Administered for Prevention and Treatment of Cancer-Related Infections

424

Drug Utilization Evaluation of Antibiotics in Burn Patients at a Referral Teaching Hospital

425

Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital

426

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

427

Drug Utilization Evaluation of Carbapenems in a Teaching Hospital in Tabriz-Iran

428

Drug Utilization Evaluation of Cefepime and Meropenem Based on the Infectious Disease Society of America and Defined Daily Dose Guidelines at the Payambare-Azam Bandar Abbas Hospital: A Retrospective Study

429

Drug Utilization Evaluation of Colistin: A Retrospective Study

430

Drug Utilization Evaluation of Imipenem and Intravenous Ciprofloxacin in a Teaching Hospital

431

Drug Utilization Evaluation of Imipenem in an Educational Hospital in Mazandaran Province

432

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation

433

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

434

Drug utilization evaluation of Rivaroxaban in both inpatient and outpatient settings: Using standard guidelines

435

Drug utilization evaluation of third generation cephalosporins using core drug use indicators

436

Drug Utilization Evaluation of Two Broad-Spectrum Antimicrobials: Cefepime and Piperacillin/Tazobactam in a Teaching Hospital in Tabriz, Iran

437

Drug Utilization Evaluation of Vancomycin in a Referral Infectious Center in Mazandaran Province

438

Drug Utilization Evaluation of Vancomycin in Pediatric Department

439

Drug utilization patterns in Rawalpindi and Islamabad, Pakistan

440

Drug Utilization Review of Conventional Amphotericin B in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplant Center

441

Drug Utilization Review of Vancomycin in Febrile Neutropenic Patients Hospitalized at a Bone Marrow Transplantation Center

442

Drug Utilization Study on Acute Poisoning Cases Treated at a Tertiary Care Hospital in Western Part of India

443

Drug with potential to clear amyloid

444

Drug/device combinations for local drug therapies and infection prophylaxis

445

Drug-Coated Balloons for Infrapopliteal Disease: Digging Deep to Understand the Impact of a Negative Trial

446

Drug-company sponsorship and the Declaration of Helsinki

447

Drug-company sponsorship and the Declaration of Helsinki

448

Drug-delivering coronary artery stents: bare metal threatened by extinction?

449

Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal

450

Drug–DNA interaction: A theoretical study on the binding of thionine with DNAs of varying base composition

451

Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry

452

Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population

453

Drug-drug co-crystals

454

Drug-Drug Interaction Extraction via Convolutional Neural Networks

455

Drug–drug interaction mediated by inhibition and induction of P-glycoprotein

456

Drug-Drug Interactions among Kidney Transplant Recipients in The Outpatient Setting

457

Drug‐Drug Interactions in Elderly Adults in Dentistry Care: a Cross-Sectional Study

458

Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature

459

Drug-Drug Interactions: Influence of verapamil on the pharmacokinetics of sitagliptin in rats and Ex vivo models

460

Drug‑drug Interactions: The Importance of Medication Reconciliation (Letters to the Editor Volume 6 - Issue 1 - January-March 2017 )

461

Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G

462

Drug-Drug/Drug-Excipient Compatibility Studies on Curcumin using Non-Thermal Methods

463

Drug-Drug-Induced Akathisia: Two Case Reports

464

Drug-efficacy depends on the inhibitor type and the target position in a metabolic network—A systematic study

465

Drug-eluted stent fracture occurred within 3 years lead to chronic total occlusion and aneurysm

466

Drug-eluting Balloon (DEB) for De-Novo Coronary Artery Disease and In-stent Restenosis: Immediate and Intermediate Term Results from a Prospective Registry

467

Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis

468

Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia: 12-Month Results From the IN.PACT DEEP Randomized Trial

469

Drug-eluting bioabsorbable stents – An in vitro study

470

Drug-Eluting Compared With Bare-Metal Coronary Stents Among Elderly Patients Original Research Article

471

Drug-eluting stent fracture occurred within 2 days after stent implantation

472

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation

473

Drug-Eluting Stent Fracture: Promise and Performance

474

Drug-Eluting Stent Implantation and Coronary Collateral Growth Attenuation: Is Drug the Only Culprit?

475

Drug-Eluting Stent Implantation May Not Affect Vasomotor Function in Early Phase

476

Drug-Eluting Stent Restenosis: The Pattern Predicts the Outcome Original Research Article

477

Drug-Eluting Stent Thrombosis: A Pooled Analysis

478

Drug-Eluting Stent Thrombosis: A Pooled Analysis: Reply

479

Drug-Eluting Stent Thrombosis: Increasingly Recognized But Too Frequently Overemphasized

480

Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies Original Research Article

481

Drug-Eluting Stent Thrombosis: Results From the Multicenter Spanish Registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) Original Research Article

482

Drug-Eluting Stent-Induced Left Anterior Descending Coronary Artery Aneurysm: Repair by Pericardial Patch—Where Are We Headed?

483

Drug-Eluting Stent-Induced Vascular Dysfunction: Common and Missing Links

484

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus: The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent I

485

Drug-Eluting Stenting for Unprotected Left Main Coronary Artery Disease: Are We Ready to Replace Bypass Surgery?

486

Drug-Eluting stents

487

Drug-Eluting Stents “Next Generation” Basic Science Workshop

488

Drug-eluting stents 1— preclinical

489

Drug-eluting stents 2-economics and cost effectiveness

490

Drug-eluting stents 3-restenosis following stenting with drug-eluting stents

491

Drug-eluting stents 4-paclitaxel, everolimus, and other agents

492

Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: Combination therapy for the future

493

Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited

494

Drug-eluting stents and late stent thrombosis

495

Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction

496

Drug-Eluting Stents Are Safe and Effective: Right or Wrong?

497

Drug-Eluting Stents for Acute Myocardial Infarction

498

Drug-eluting stents for coronary artery disease: A review

499

Drug-Eluting Stents for Critical Limb Ischemia

500

Drug-eluting stents for diabetes mellitus: A rush to judgment? Review Article

501

Drug-Eluting Stents for Saphenous Vein Graft Lesions: The Limits of Evidence

502

Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stents

503

Drug-eluting stents in diabetics & Complex patient groups

504

Drug-Eluting Stents in Heart Transplant Recipients

505

Drug-Eluting Stents in the Treatment of Intermediate Lesions: Pooled Analysis From Four Randomized Trials Original Research Article

506

Drug-eluting stents in total coronary occlusions: Another piece of the puzzle solved?

507

Drug-eluting stents in vascular intervention

508

Drug-Eluting Stents Versus Bare Metal Stents for Narrowing in Saphenous Vein Grafts

509

Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions (A Meta-Analysis)

510

Drug-Eluting Stents Versus Bilateral Internal Thoracic Grafting for Multivessel Coronary Disease

511

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus

512

Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

513

Drug-eluting stents, 5-sirolimus stents and oral rapamycin

514

Drug-eluting stents: A multidisciplinary success story

515

Drug-eluting stents: an innovative multidisciplinary drug delivery platform

516

Drug-eluting stents: Beyond the hyperbole

517

Drug-eluting stents: Factors governing local pharmacokinetics

518

Drug-eluting stents: Failures and restenosis

519

Drug-eluting stents: insights into safety and indications

520

Drug-eluting stents: is new necessarily better?

521

Drug-Eluting Stents: Is Their Future as Bright as Their Past?

522

Drug-eluting stents: Lesion subsets

523

Drug-Eluting Stents: Life Insurance With a Better Death Benefit

524

Drug-eluting stents: Miscellaneous

525

Drug-eluting stents: Patient and lesion subsets

526

Drug-eluting stents: Registries and trials

527

Drug-eluting stents: Registries and trials

528

Drug-eluting stents: results, promises and problems

529

Drug-eluting stents: some bare facts

530

Drug-Eluting Versus Bare Metal Stents for Saphenous Vein Graft Intervention

531

Drug-evaluation harmonisation will lead to fewer animal tests

532

Drug-exposed infant cases in juvenile court: risk factors and court outcomes

533

Drug-Facilitated Effects on Protective Airway Reflexes During Out-of-Hospital Endotracheal Intubation

534

Drug-free in vitro activation and autologous transplantation in infertile women with diminished ovarian reserve: An experimental pilot study

535

Drugging Drug Resistance

536

Drugging the Bad “AKT-TOR” to Overcome TKI-Resistant Lung Cancer

537

Drugging the Undruggable

538

Drug–GSH interaction on GSH–Au modified electrodes: A cyclic voltammetry and electrochemical impedance spectroscopy study

539

Drug-hormone interactions on neurobehavioral responses in human neonates

540

Drug-induced Acute Interstitial Nephritis Pathology, Pathogenesis, and Treatment

541

Drug-induced amnesia impairs implicit relational memory

542

Drug-induced and toxic myopathies

543

Drug-Induced Apnea in Children Admitted to Loghman Hakim Hospital, Tehran, Iran

544

Drug-induced atrial fibrillation Review Article

545

Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug Original Research Article

546

Drug-induced autoimmunity

547

Drug-Induced Brugada Syndrome in Children: Clinical Features, Device-Based Management, and Long-Term Follow-Up

548

Drug-Induced Bullous Pemphigoid: Rapid Resolution with Corticosteroid Therapy

549

Drug-Induced by Systemic Lupus Erythematosus Presenting as Recurrent Pericardial Effusion After Mitral Valve Repair

550

Drug-induced cholestasis

551

Drug-induced gingival overgrowth and its tentative pharmacotherapy

552

Drug-Induced Gingival Overgrowth in an 8-Year-Old Girl: A Case Report

553

Drug-induced headaches

554

Drug-induced headaches

555

Drug-induced heart failure

556

drug-induced hemophagocytosis

557

Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization

558

Drug-induced hyperkalemia

559

Drug-induced hyperkalemia: old culprits and new offenders

560

Drug-induced hyperkalemia: The reply:

561

Drug-Induced Hypersensitivity Syndrome (DRESS) by Phenobarbital - Case Report and Literature Review

562

Drug-Induced Hypersensitivity Syndrome Caused by Carbamazepine Used for the Treatment of Trigeminal Neuralgia

563

Drug-induced interstitial nephritis in a child with idiopathic nephrotic syndrome

564

Drug-Induced Lichen Planus

565

Drug-Induced Linear Immunoglobulin-A Bullous Dermatosis

566

Drug-induced liver diseases

567

Drug-induced liver injury following positive drug rechallenge

568

Drug-Induced Long QT Syndrome and Exome Sequencing: Chinese Shadows Link Past and Future

569

Drug-induced lupus erythematosus

570

Drug-Induced Lupus Erythematosus

571

Drug-induced methemoglobinemia during thoracoscopic lung biopsy

572

Drug-induced myocardial infarction in young patients: Report of two cases

573

Drug-induced Nephrotoxicity and Medicinal Plants

574

Drug-induced neurological disorders : by K.K. Jain, 1996, Hogrefe & Huber Publishers, Seattle, USA, 389 pages, US$ 79, ISBN 0-88937-154-7

575

Drug-Induced Pemphigoid:: Bullous and Cicatricial

576

Drug-Induced Pemphigus

577

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

578

Drug-Induced QT Interval Prolongation and Torsade De Pointes:Identification of Risk Factors

579

Drug-induced renal disorders

580

Drug-Induced Scleroderma and Sclerodermiform Conditions

581

Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin

582

Drug-induced systemic lupus erythematosus and TNF-α blockers

583

Drug-induced systemic lupus erythematosus and TNF-α blockers

584

Drug-induced systemic lupus erythematosus and TNF-α blockers

585

Drug-induced systemic lupus erythematosus associated with etanercept therapy

586

Drug-induced torsades de pointes in one patient with congenital long QT syndrome

587

Drug-Induced Toxic Epidermal Necrolysis

588

Drug-induced tremors

589

DRUG-INDUCED VASCULITIS IN A BREAST CANCER PATIENT RECEIVING CHEMOTHERAPY

590

Drug–lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces

591

Drug-licensing anomalies and Parkinsonʹs disease

592

Drug-loaded chondroitin sulfate-based nanogels: Preparation and characterization

593

Drug-loaded electrospun nanofibrous sheets as barriers against postsurgical adhesions in mice model

594

Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells

595

Drug-lunch alert

596

Drugmaker seeks permissions to collaborate on Cuban vaccine

597

Drug–protein interactions assessed by fluorescence measurements in the real complexes and in model dyads

598

Drug-related Death low Registration in Iran: A Mixed Method Approach for Causes, Recommendations to Solve This Problem and Geographical Evaluation of an Intervention

599

Drug-related deaths by region, sex, and age group per 100 injecting drug users in Scotland, 2000–01

600

Drug-related killings: a case of mistaken identity Review Article

601

Drug-related problems (DRPs) identified from geriatric medication safety review clinics

602

Drug-related Problems Among Type 2 Diabetic Patients With Hypertension in a Tertiary Care Hospital in Lebanon: A Cross-sectional Study

603

Drug‑related Problems in Hypertensive Patients: A Cross‑sectional Study from Indonesia

604

Drug-related Problems in Solid-Organ Transplant Recipients Hospitalized for COVID-19: An Experience of a Referral Tertiary Center in Iran

605

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

606

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

607

Drug-resistant enteric fever in the UK

608

Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

609

Drug-resistant genotyping in HIV-1 therapy

610

Drug-resistant genotyping in HIV-1 therapy

611

Drug-resistant genotyping in HIV-1 therapy

612

Drug-resistant genotyping in HIV-1 therapy

613

Drug-resistant genotyping in HIV-1 therapy

614

Drug-resistant gonorrhoeae spread in the USA

615

Drug-Resistant Phosphatidylinositol 3-Kinase: Guidance for the Preemptive Strike

616

Drug-resistant Pneumocystis carinii

617

Drug-Resistant Proteus Virulence Factors Characterization and Their Inhibition Using Probiotic Bacteria

618

Drug-resistant pulmonary tuberculosis in western Turkey : Prevalence, clinical characteristics and treatment outcome

619

Drug-resistant strains of HIV increase sharply in Japan

620

Drug-resistant Streptococcus pneumoniae: rational antibiotic choices

621

Drug-resistant tuberculosis

622

Drug-Resistant Tuberculosis and Group 5 Anti-Tuberculosis Drugs

623

Drug-resistant tuberculosis in Taipei, 1996-1999

624

Drug-resistant tuberculosis: desperate measures?

625

Drugs & devices in brief

626

Drugs against superbugs: private lessons from bacteriophages

627

Drugs and a dark future

628

Drugs and Addictive Behaviour: A Guide to Treatment (3rd edition): Hamid Ghodse, Cambridge University Press 2002. £39.95, 520 pages

629

Drugs and demons

630

Drugs and mental health

631

Drugs and narcotics in history : Edited by Roy Porter and Mikulas Teich. Cambridge University Press, Cambridge, 1995. xii + 227 pp., U.S.$49.95 (cloth)

632

Drugs and nutrition: how side effects can influence nutritional intake

633

Drugs and nutrition: Important drug-nutrient interactions

634

Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea

635

Drugs and pests: intertemporal production externalities

636

Drugs and Pharmacology for Nurses, 12th edn, S.J. Hopkins. Churchill Livingstone (1995), ISBN: 0-443-05249-2

637

Drugs and risk-taking in tourism

638

Drugs and the art of Fred Tomaselli

639

Drugs and the immune system: the emerging era of immunopharmacology

640

Drugs deaths drop in Switzerland

641

Drugs elevating extracellular adenosine enhance cell cycling of hematopoietic progenitor cells as inferred from the cytotoxic effects of 5-fluorouracil

642

Drugs Expiration Date Dilemma!

643

Drugs for Left Ventricular Remodeling in Heart Failure

644

Drugs for obstetric conditions

645

Drugs for the gynecologist to prescribe in the prevention of breast cancer: Current status and future trends

646

Drugs for vascular dementia

647

Drugs in Exacerbation and Provocation of Psoriasis

648

Drugs in Nursing Practice: C R Henney, RJ Dow, A M Macconnachie Churchill Livingstone, 1995, 5th edn ISBN 0-443-05235-2, 482 pages Price £12.95

649

Drugs in Pregnancy and Lactation, Sixth Edition: Gerald G. Briggs, Roger K. Freeman, & Sumner J.Yaffe. ISBN 0-7817-3203-4, Lippincott Williams & Wilkins, Philadelphia, 2002, 1595 pp

650

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review

651

Drugs in the Plant

652

Drugs in the postgenomic era

653

Drugs Induced Alzheimer’s Disease in Animal Model

654

Drugs lose out to revascularisation in symptom-free coronary disease

655

DRUGS MINIMIZING BLOOD LOSS DURING LIVER TRANSPLANTATION

656

Drugs of Abuse and Alcohol in Weekend Drivers Involved in Car Crashes in Belgium, , ,

657

Drugs of Abuse and Immuno-Modulation

658

Drugs of abuse and reward comparison: a brief review

659

Drugs of abuse and the elicitation of human aggressive behavior

660

Drugs of abuse in oral fluid collected by two different sample kits – Stability testing and validation using ultra performance tandem mass spectrometry analysis

661

Drugs of abuse in pregnancy

662

Drugs of abuse in urban groundwater. A case study: Barcelona Original Research Article

663

Drugs or Implantable Cardioverter-Defibrillators in Patients with Poor Left Ventricular Function?

664

Drugs Prescribed by Dentists in Fars Province, Iran

665

Drugs solubilization in ascorbyl–decanoate micellar solutions

666

667

Drugs Used in Pregnancy

668

Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action

669

Drugs, diet and disease

670

Drugs, HIV Treatment and Harm Reduction Services for Afghan Refugees in Iran

671

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

672

DRUGS-FACILITATED STREET AND TRAVEL RELATED CRIMES: A NEW PUBLIC HEALTH ISSUE

673

Drug-testing practices in US hotels

674

Drug-trial “irregularities” uncovered in Argentina

675

Drug-trial compensation demands in lreland

676

Drug-use behavior and correlates in people with schizophrenia

677

Drug-use initiation and conduct disorder among adolescents in drug treatment

678

Druid wins Baan contract with Weston Aerospace

679

Drum agglomeration behavior of nickel laterite ore: Effect of process variables

680

Drum granulation of NPK fertilizers

681

Drum leaching tests in iron removal from quartz using oxalic and sulphuric acids

682

Drum Sound Recognition for Polyphonic Audio Signals by Adaptation and Matching of Spectrogram Templates With Harmonic Structure Suppression

683

Drum-boiler dynamics

684

Drum-like silencers using magnetic forces in a pressurized cavity

685

686

Drunk drivers in the courts: Legal and extra-legal factors affecting pleas and sentences

687

Drunk driving and mental disorders

688

Drunk driving and mental disorders

689

Drunk, but not blind: The effects of alcohol intoxication on change blindness

690

Drupangtonine, a novel antileukemic alkaloid from Cephalotaxus harringtonia var. drupacea

691

Drushbametrics — My Russian adventures

692

Dry aging of beef in a bag highly permeable to water vapour

693

Dry air effects on the copper oxides sensitive layers formation for ethanol vapor detection

694

Dry anaerobic digestion of food waste under mesophilic conditions: Performance and methanogenic community analysis

695

Dry and lubricated wear resistance of mechanically-alloyed aluminium-base sintered composites

696

Dry and semi-dry machining using finely crystallized diamond coating cutting tools

697

Dry and Wet Abrasive Conditions of Fe-C-B Wear Resistance Hardfacing Alloy on Mild Steel

698

Dry and wet abrasive resistance of Inconel 600 and stellite

699

Dry and wet atmospheric deposition of nitrogen and phosphorus in Singapore

700

Dry and wet deposition of elemental carbon on a tropical forest in Thailand

701

Dry and wet deposition of elements in Hong Kong

702

Dry and wet deposition of mercury near a chlor-alkali plant

703

Dry and wet deposition of nutrients from the tropical Atlantic atmosphere: Links to primary productivity and nitrogen fixation

704

Dry and wet deposition of water-insoluble dust and water-soluble chemical species during spring 2007 in Tsukuba, Japan

705

Dry and wet rainy seasons in the Mantaro river basin (Central Peruvian Andes)

706

Dry and wet sliding wear of ITO-coated PET components used in flexible optoelectronic applications

707

Dry and Wet Wear Characteristic of TiO2 Thin Film Prepared by Magnetic Sputtering in Ringer Solution

708

Dry ashing of organic rich matrices with palladium for the determination of arsenic using inductively coupled plasma-mass spectrometry Original Research Article

709

Dry atmospheric deposition and deposition velocities of dicamba, 2,4-dichlorophenoxyacetic acid and γ-1,2,3,4,5,6-hexachlorocyclohexane Original Research Article

710

Dry atmospheric deposition and diazotrophy as sources of new nitrogen to northwestern Mediterranean oligotrophic surface waters

711

Dry atmospheric deposition rates of metals along a coastal transect in southern California

712

Dry atmospheric fluxes of trace metals (Al, Fe, Mn, Pb, Cd, Zn, Cu) over the Levantine Basin: A refined assessment

713

Dry atmospheric inputs of trace metals at the Mediterranean coast of Israel (SE Mediterranean): sources and fluxes

714

Dry bag isostatic pressing for improved green strength of surrogate nuclear fuel pellets

715

Dry Bean Intake of Women Ages 19-45

716

Dry Bean Production in Zero and Conventional Tillage

717

Dry beneficiation of Slovakian coal

718

Dry beneficiation technology of coal with an air dense-medium fluidized bed

719

Dry boards as load bearing element in the profiled steel sheet dry board floor panel system—structural performance and applications

720

Dry catalyst impregnation in a double cone blender: A computational and experimental analysis

721

Dry catalytic partial oxidation of diesel–fuel distillates into syngas

722

Dry citrate-precursor synthesized nanocrystalline cobalt oxide as highly active catalyst for total oxidation of propane

723

Dry cleaning for metallic contaminants removal as the second cleaning process after the CMP process

724

Dry cleaning of metal surfaces by a vacuum arc

725

Dry climate near the Western Pacific Warm Pool: Pleistocene caliches of the Nansha Islands, South China Sea

726

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

727

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

728

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

729

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

730

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

731

Dry coastal ecosystems. Ecosystems of the world, volumes 2A and 2B: E. van der Maarel (Editor). Elsevier, Amsterdam, 1993. Vol. 2A: Dfl. 430, ISBN 0-444-87348-1, 600 pp. Vol. 2B: Dfl. 470, ISBN 0-444-87349-X, 664 p

732

Dry coating of talc particles with fumed silica: Influence of the silica concentration on the wettability and dispersibility of the composite particles

733

Dry coating polymer powder particles with deagglomerated carbon nanotubes to improve their dispersion in nanocomposites

734

Dry coatings and ecodesign part. 1 — Environmental performances and chemical properties

735

Dry coatings and ecodesign: Part. 2 — Tribological performances

736

Dry cooling towers as condensers for geothermal power plants

737

Dry cooling with night cool storage to enhance solar power plants performance in extreme conditions areas

738

Dry cupping therapy and the wellness management of health travelers

739

Dry cutting performance of partially filtered arc deposited titanium aluminium nitride coatings with various metal nitride base coatings

740

Dry deep drawability of A5052 aluminum alloy sheet with DLC-coating

741

Dry degumming of vegetable oils by membrane filtration Original Research Article

742

Dry dense medium separation of iron ore using a gas–solid fluidized bed

743

Dry densification of carbon nanotube bundles Original Research Article

744

Dry deposition (downward, upward) concentration study of particulates and heavy metals during daytime, nighttime period at the traffic sampling site of Sha-Lu, Taiwan

745

Dry deposition and concentration of marine aerosols in a coastal area, SW Sweden

746

Dry deposition and foliar leaching of mercury and selected trace elements in deciduous forest throughfall

747

Dry deposition and interception of 4–22 μm diameter particles to a lettuce crop

748

Dry deposition and internal circulation of nitrogen, sulphur and base cations to a coniferous forest

749

Dry deposition and particle-size distribution of phosphorus in the marine atmosphere over the northeastern coast of Taiwan

750

Dry deposition and particle-size distributions of polycyclic aromatic hydrocarbons in the ambient air of a petrochemical plant

751

Dry deposition and resuspension of particle-associated metals near a freeway in Los Angeles

752

Dry deposition and soil–air gas exchange of polychlorinated biphenyls (PCBs) in an industrial area

753

Dry deposition calculations for the clean air status and trends network

754

Dry deposition effect of marine aerosol to the building stone of the medieval city of Rhodes, Greece

755

Dry deposition fluxes and atmospheric size distributions of mass, al, and mg measured in southern Lake Michigan during aeolos

756

Dry deposition fluxes and deposition velocities of PAHs at an urban site in Turkey

757

Dry deposition fluxes and velocities of polychlorinated biphenyls (PCBs) associated with particles

758

Dry deposition fluxes of ambient particulate heavy metals in a small city, Korea

759

Dry deposition measured with a water surface sampler: a comparison to modeled results

760

Dry deposition model for atmospheric particles

761

Dry deposition modelling of atmospheric aerosols from a lead smelting industry

762

Dry deposition of 214Pb to conifers

763

Dry deposition of acidic air pollutants to tree leaves, determined by a modified leaf-washing technique

764

Dry deposition of aerosol particles within model spruce canopies

765

Dry deposition of ammonia, nitric acid, ammonium, and nitrate to alpine tundra at Niwot Ridge, Colorado

766

Dry deposition of atmospheric polycyclic aromatic hydrocarbons (PAHs) in the southeast suburb of Beijing, China

767

Dry deposition of electrically charged aerosols

768

Dry deposition of gaseous elemental mercury to plants and soils using mercury stable isotopes in a controlled environment

769

Dry deposition of gaseous oxidized mercury in Western Maryland Original Research Article

770

Dry deposition of gaseous radioiodine and particulate radiocaesium onto leafy vegetables Original Research Article

771

Dry deposition of large, airborne particles onto a surrogate surface

772

Dry Deposition of Nonspherical Particles on Natural and Surrogate Surfaces

773

Dry deposition of ozone on building materials. Chamber measurements and modelling of the time-dependent deposition

774

Dry deposition of particles and canopy exchange: Comparison of wet, bulk and throughfall deposition at five forest sites in Italy

775

Dry deposition of particles in a coastal forest

776

Dry deposition of particles to building surfaces and soiling

777

Dry deposition of particles to wave surfaces: I. Mathematical modeling

778

Dry deposition of particles to wave surfaces: II. Wind tunnel experiments

779

Dry deposition of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) in ambient air

780

Dry deposition of polycyclic aromatic hydrocarbons in urban and rural sites of Western Greece

781

Dry deposition of reactive nitrogen to marine environments: recent advances and remaining uncertainties

782

Dry Deposition of SO2 Over Dry Dipterocarp Forest, Thailand

783

Dry deposition of sulfate-containing particulate at the highway intersection, coastal and suburban areas

784

Dry deposition of sulphate and nitrate to polypropylene surfaces in a semi-arid area of India

785

Dry deposition of sulphur dioxide and ammonia on wet surfaces and the surface oxidation kinetics of bisulphite

786

Dry deposition of sulphur over eastern South Africa

787

Dry deposition profile of small particles within a model spruce canopy

788

Dry deposition to forests—On the use of data from clearings

789

Dry deposition to pine of sulphur dioxide and ozone at low concentration

790

Dry deposition velocity of PM2.5 ammonium sulfate particles to a Norway spruce forest on the basis of S- and N-balance estimations

791

Dry deposition velocity of sulfur dioxide over rice paddy in the tropical region

792

Dry deposition washoff and dew on the surfaces of pine foliage on the urban- and mountain-facing sides of Mt. Gokurakuji, western Japan

793

Dry deposition, concentration and gas/particle partitioning of atmospheric carbazole

794

Dry deposition, ionic species measured and source interpretation during seasonal cycle at offshore areas near Taiwan Strait

795

Dry deposition, seasonal variation and source interpretation of ionic species at Abali, Firouzkouh and Varamin, Tehran Province, Iran

796

Dry dilute acid pretreatment by co-currently feeding of corn stover feedstock and dilute acid solution without impregnation

797

Dry dispersion of fine particles in gaseous phase

798

Dry dispersion of plant pulp in concrete and use thereof

799

Dry drainage: A sustainable solution to waterlogging and salinity problems in irrigation areas?

800

Dry elasto-plastic contact of nominally flat surfaces

801

Dry electrical discharge machining of cemented carbide

802

Dry etch characteristics of Al-Nd films for TFT-LCD

803

Dry etch chemistries for TiO2 thin films

804

Dry etching and implantation characteristics of III-N alloys

805

Dry etching and implantation characteristics of III-N alloys

806

Dry etching characteristics and surface reconstruction of Cl/Si(1 1 3)

807

Dry etching characteristics of (Ba0.6,Sr0.4)TiO3 thin films in high density CF4/Ar plasma

808

Dry etching characteristics of GaN for blue/green light-emitting diode fabrication

809

Dry etching characteristics of GaN using Cl2/BCl3 inductively coupled plasmas

810

Dry etching mechanism of copper and magnetic materials with UV illumination

811

Dry etching of AlTiC with CF/sub 4/ and H/sub 2/ for slider fabrication

812

Dry etching of bulk single-crystal ZnO in CH4/H2-based plasma chemistries

813

Dry etching of CuCrO2 thin films

814

Dry etching of ITO by magnetic pole enhanced inductively coupled plasma for display and biosensing devices

815

Dry etching of MgCaO gate dielectric and passivation layers on GaN

816

Dry etching of sapphire substrate for device separation in chlorine-based inductively coupled plasmas

817

Dry etching of surface textured zinc oxide using a remote argon–hydrogen plasma

818

Dry etching of zinc-oxide and indium-zinc-oxide in IBr and BI3 plasma chemistries

819

Dry excimer laser cleaning applied to nuclear decontamination

820

Dry Eye (Keratoconjunctiviti icca), Rheumatoid Arthriti, and jögren’ yndrome

821

Dry eye after laer in itu keratomileui

822

Dry eye after LAIK enhancement by flap lifting

823

Dry Eye after LASIK for Myopia

824

Dry eye disease and depression-anxiety-stress: A hospital-based case control study in Turkey

825

Dry eye disease: A review of diagnostic approaches and treatments

826

Dry eye in diabetic patient

827

Dry eye signs and symptoms in night-time workers

828

Dry Eye Syndrome

829

Dry Eye: an Inflammatory Ocular Disease

830

Dry fabrication process for heterojunction solar cells through in-situ plasma cleaning and passivation

831

Dry farming with soils under natural tephra cover in Lanzarote, Spain

832

Dry feed for Artemia: its effect on performance, physiology, immune responses and bacterial resistance

833

Dry fermented sausages enriched with lycopene from tomato peel

834

Dry fine comminution in a stirred media mill—MaxxMill

835

Dry formation of low-density Nomex™ rejects-based activated carbon fiber composites

836

Dry fractionation process as an important step in current and future lignocellulose biorefineries: A review

837

Dry friction and sliding wear of EPDM rubbers against steel as a function of carbon black content

838

Dry friction and wear characteristics of nickel/carbon nanotube electroless composite deposits

839

Dry Friction and Wear Performance of Micro Surface Textures Generated by Ultrasonic Assisted Face Turning

840

Dry friction of steel under high pressure in quasi-static conditions

841

Dry friction: modeling and energy flow

842

Dry galloping characteristics and its mechanism of inclined/yawed cables

843

Dry gas cleaning in coal gasification systems for fuel cells using composite sorbents

844

Dry gas cleaning of coexisting SOx and NOx by manganese ore

845

Dry gas cleaning process by adsorption of H2S into activated cokes in gasification of carbon resources

846

Dry gel conversion synthesis of SAPO-34 nanocrystals

847

Dry Granular Flow Modelling Including Erosion and Deposition

848

Dry grinding kinetics of binary mixtures of ceramic raw materials by Bond milling

849

Dry grinding kinetics of colemanite

850

Dry heat stress stability evaluation of casein peptide mixture

851

Dry Hot and Cool Tropical Climate Attenuation models at VHF

852

Dry ice – an eco-friendly alternative for ammonium reduction in leather manufacturing

853

Dry ice blasting as pretreatment of aluminum surfaces to improve the adhesive strength of aluminum bonding joints

854

Dry ice-originated supercritical and liquid carbon dioxide extraction of organic pollutants from environmental samples

855

Dry Joint Stone Masonry Walls Subjected to In-Plane Combined Loading

856

Dry Joint Stone Masonry Walls Subjected to In-Plane Combined Loading

857

Dry kiln scheduling in furniture production

858

Dry kiln scheduling in furniture production

859

Dry laser cleaning of mechanically thin films

860

Dry layer preparation and characterisation of polymer electrolyte fuel cell components

861

Dry Lips as a Possible New Clinical Sign in Diagnosis of Appendicitis in Adults: A Short Report

862

Dry lubricant for cold drawing low-carbon steel wire

863

Dry machining — commercial viability through filtered arc vapour deposited coatings

864

Dry Machining and Minimum Quantity Lubrication

865

Dry machining of aluminum–silicon alloy using polished CVD diamond-coated cutting tools inserts

866

Dry machining of Inconel 718, workpiece surface integrity

867

Dry machining: Machining of the future

868

Dry Magnus separation

869

Dry mass production and leaf area development of field-grown ornamental conifers: measurements and simulation

870

Dry mass production in seedlings of Norway spruce infected by the needle rust Chrysomyxa rhododendri

871

Dry Matter Accumulation and Associated Changes in Biochemical Parameters during Wheat Grain Development

872

Dry matter accumulation and forage quality characteristics of different soybean genotypes

873

Dry Matter Accumulation and Partitioning as Affected by Thinning in a Non-Prolific Maize Hybrid

874

Dry matter accumulation and partitioning in cotton (Gossypium hirsutum L.) as influenced by potassium fertilization

875

Dry Matter Accumulation in Linseed (Linum usitatissimum L.)

876

Dry matter amounts and increment in 21- to 91-year-old common alder and grey alder and some practical implications

877

Dry Matter and Crude Protein Degradability of Mopane Worm (Imbrasia belina) in Rumen of Steers

878

Dry Matter and Essential Oil Yield Changes of Lavandula officinalis under Cowmanure and Vermicompost Application

879

Dry Matter and Leaf Structure in Young Wheat Plants as Affected by Cadmium, Lead, and Nickel

880

Dry Matter and Nitrogen Remobilization of Two Wheat Genotypes under Post - anthesis Water Stress Conditions

881

Dry matter and root colonization of plants by indigenous arbuscular mycorrhizal fungi with physical fractions of dry olive mill residue inoculated with saprophytic fungi

882

Dry Matter Intake and Digestibility in Weast African Dwarf Goats Fed Raw or Processed

883

Dry matter intake and digestibility of temperate pastures supplemented with sorghum grain in wethers and heifers

884

Dry matter intake and eating rate of grass by dairy cows is restricted by internal, but not external water

885

Dry matter intake, in vivo nutrient digestibility and concentration of minerals in the blood and urine of steers fed rice straw treated with wood ash extract

886

Dry Matter Intake, Milk Yield and Milk Fatty Acid Composition of Dairy Cows Fed Raw or Microwave Irradiated Safflower Seed as a Substitution to Cottonseed

887

Dry matter losses in combination with gaseous emissions during the storage of forest residues

888

Dry matter partitioning and physiological responses of Coffea arabica varieties to soil moisture deficit stress at the seedling stage in Southwest Ethiopia

889

Dry matter partitioning and quality of Miscanthus, Panicum, and Saccharum genotypes in Arkansas, USA

890

Dry Matter Partitioning between Plant Organs in Wheat Cultivars Differing in Productivity and Drought Resistance

891

Dry Matter Partitioning in Linseed (Linum usitatissimum L.)

892

Dry Matter Partitioning to Stem at Full Maturity Affects Stem Desiccation and Combine Harvest Maturity in Soybeans

893

Dry Matter Partitioning, Growth Analysis and Water Use Efficiency Response of Oats (Avena sativa L.) to Excessive Nitrogen and Phosphorus Application

894

Dry matter remobilization and yield of durum wheat in Ardabil, Iran as affected by plant density and N fertilization level

895

Dry Matter Yield and Chemical Composition of Sorghum Cultivars with Varying Planting Density and Sowing Date

896

DRY MATTER YIELD AND FORAGE QUALITY OF OAT, BARLEY AND CANOLA MIXTURE

897

Dry matter yield and nutritive value of pea/wheat bi-crops differing in maturity at harvest, pea to wheat ratio and pea variety

898

Dry matter yield, feeding value, and antioxidant activity in Mediterranean chicory (Cichorium intybus L.) germplasm

899

Dry matter yield, forage quality and persistence of tall fescue (Festuca arundinacea) cultivars compared with perennial ryegrass (Lolium perenne) in a subtropical environment

900

Dry mechanochemical synthesis of hydroxyapatites from DCPD and CaO: influence of instrumental parameters on the reaction kinetics

901

DRY METHOD FOR PREPARATION OF INULIN BIOMASS AS A FEEDSTOCK FOR ETHANOL FERMENTATION

902

Dry micro-electro-discharge machining of carbon-nanotube forests using sulphur-hexafluoride Original Research Article

903

Dry milling characteristics of microwave dried maize grains (Zea mays L.) Original Research Article

904

Dry milling of field pea (Pisum sativum L.) groats prior to wet fractionation influences the starch yield and purity

905

Dry Mixing of Wheat Flours: Effect of Particle Properties and Blending Ratio

906

Dry mycelium of Penicillium chrysogenum induces expression of pathogenesis-related protein genes and resistance against wilt diseases in Bt transgenic cotton

907

Dry mycelium of Penicillium chrysogenum protects cotton plants against wilt diseases and increases yield under field conditions

908

Dry needling in patients with chronic heel pain due to plantar fasciitis: A single-blinded randomized clinical trial

909

Dry Needling of Tight Hamstrings in the Treatment of Chronic Low Back Pain

910

Dry Needling Plus Conventional Physiotherapy for Patients With Chronic Nonspecific Neck Pain: A Randomized Clinical Trial

911

Dry particle coating for improving the flowability of cohesive powders

912

Dry particle coating using magnetically assisted impaction coating: modification of surface properties and optimization of system and operating parameters

913

Dry particle high coating of biopowders: An energy approach

914

Dry patch interaction caused by lateral conduction in transition boiling

915

Dry periods on the NE Tibetan Plateau during the late Quaternary

916

Dry photochemical synthesis of hydrotalcite, γ-Al2O3 and TiO2 supported gold nanoparticle catalysts

917

Dry plasma synthesis of graphene oxide–Ag nanocomposites: A simple and green approach

918

Dry powder aerosol drug delivery—Opportunities for colloid and surface scientists

919

Dry powder formulation with α-glycosyltransferase-treated stevia for the effective absorption of hydrophobic bioactive compounds in crude drugs

920

Dry powder inhaler delivery of amorphous drug nanoparticles: Effects of the lactose carrier particle shape and size

921

Dry Powder Precursors of Cubic Liquid Crystalline Nanoparticles (cubosomes)

922

Dry powder preparation of inulin fructotransferase from Arthrobacter aurescens SK 8.001 fermented liquor

923

Dry powders for oral inhalation free of lactose carrier particles

924

Dry pressed ceramic tiles based on fly ash–clay body: Influence of fly ash granulometry and pentasodium triphosphate addition

925

Dry pretreatment of lignocellulose with extremely low steam and water usage for bioethanol production

926

Dry processing of borax by calcination as an alternative to wet methods

927

Dry processing of oats – Application of dry milling Original Research Article

928

Dry processing of silicon solar cells in a large area microwave plasma reactor

929

Dry reaction of indoles with carbonyl compounds on montmorillonite K10 clay: a mild, expedient synthesis of diindolylalkanes and vibrindole A

930

Dry reciprocating sliding wear behaviour of alumina–silicon carbide nanocomposite fabricated by ceramic injection molding

931

Dry reciprocating wear of Al–Si–SiCp composites: A statistical analysis

932

Dry reforming of CH4 over solid solutions of LaNi1−xCoxO3

933

Dry reforming of CH4 with Ni and Rh metal catalysts supported on SiO2 and La2O3 Original Research Article

934

Dry reforming of coke oven gases over activated carbon to produce syngas for methanol synthesis

935

Dry reforming of ethanol for hydrogen production: Thermodynamic investigation

936

Dry reforming of methane has no future for hydrogen production: Comparison with steam reforming at high pressure in standard and membrane reactors

937

Dry reforming of methane in a stagnation-flow reactor using Rh supported on strontium-substituted hexaaluminate Original Research Article

938

Dry reforming of methane in an atmospheric pressure plasma fluidized bed with Ni/γ-Al2O3 catalyst

939

Dry reforming of methane in membrane reactors using Pd and Pd–Ag composite membranes on a NaA zeolite modified porous stainless steel support

940

Dry reforming of methane on Ni–Mg–Al nano-spheroid oxide catalysts prepared by the sol–gel method from hydrotalcite-like precursors

941

Dry reforming of methane over catalysts derived from nickel-containing Mg–Al layered double hydroxides

942

Dry reforming of methane over LaNi1−yByO3±δ (B = Mg, Co) perovskites used as catalyst precursor Original Research Article

943

Dry reforming of methane over LnFe0.7Ni0.3O3−δ perovskites: Influence of Ln nature

944

Dry reforming of methane over Ni perovskite type oxides

945

Dry reforming of methane over nickel catalysts supported on magnesium aluminate spinels Original Research Article

946

Dry reforming of methane over nickel catalysts supported on the cuspidine-like phase Nd4Ga2O9

947

Dry reforming of methane over Pt/PrCeZrO catalyst: Kinetic and mechanistic features by transient studies and their modeling

948

Dry reforming of methane to syngas over La-promoted hydrotalcite clay-derived catalysts

949

Dry reforming of methane to synthesis gas on NiO–MgO nanocrystalline solid solution catalysts

950

Dry Reforming of Methane Using Cold Plasma; Kinetic Model Study

951

Dry reforming of methane using Ni–Ce catalysts supported on a modified mineral clay Original Research Article

952

Dry reforming of methane using Pd-based membrane reactors fabricated from different substrates

953

Dry reforming of methane with CO2 on an electron-activated iron catalytic bed

954

Dry reforming of propane over supported Re catalyst

955

Dry Regenerable Metal Oxide Sorbents for SO2 Removal from Flue Gases. 1. Development and Evaluation of Copper Oxide Sorbents

956

Dry rolling-sliding wear of austempered cast iron

957

Dry sausage fermented by Lactobacillus rhamnosus strains

958

Dry sausage ripening control integration of sensory-related properties

959

Dry season clouds and rainfall in northern Central America: Implications for the Mesoamerican Biological Corridor

960

Dry season herbivore densities around drinking troughs in the Kruger National Park

961

Dry season mapping of savanna forage quality, using the hyperspectral Carnegie Airborne Observatory sensor

962

Dry Season Prevalence of Bovine African Trypanosomosis in parts of Bokkos Local Government Area of Plateau State, Nigeria

963

DRY SEASON REFUGIA OF MALARIA-TRANSMITTING MOSQUITOES IN A DRY SAVANNAH ZONE OF EAST AFRICA

964

Dry season reproductive depression of Anopheles gambiae in the Sahel

965

Dry Season Salinity Changes in Arid Estuaries Fringed by Mangroves and Saltflats

966

Dry season supplementation of goats tethered on range supplemented with cowpea or groundnut residues with or without fresh leucaena leaves

967

Dry season water uptake by two dominant canopy tree species in a tropical seasonal rainforest of Xishuangbanna, SW China

968

Dry season water use patterns underGuiera senegalensisL. shrubs in a tropical savanna

969

Dry self-lubricating composites

970

Dry separation of particulate iron ore using density-segregation in a gas–solid fluidized bed

971

Dry separation of respirable lunar dust: Providing samples for the lunar airborne dust toxicity advisory group

972

Dry sex in Zimbabwe and implications for condom use

973

Dry skin and moisturizers

974

Dry sliding and boundary lubrication performance of a UHMWPE/CNTs nanocomposite coating on steel substrates at elevated temperatures

975

Dry sliding and tribocorrosion behaviour of hot pressed CoCrMo biomedical alloy as compared with the cast CoCrMo and Ti6Al4V alloys

976

Dry Sliding Behavior of Carbon-based Brake Pad Materials

977

Dry sliding behaviour of hydrogenated amorphous carbon (a-C:H) coatings on Ti-6Al-4V

978

Dry Sliding Behaviour Study of Novel Low-metallic Friction Materials by using DoE-Taguchi Method

979

Dry sliding friction and wear behavior of woodceramics/Al–Si composites

980

Dry sliding friction and wear behavior of woodceramics/Al–Si composites

981

Dry sliding friction and wear behavior of woodceramics/Al–Si composites

982

Dry sliding friction and wear behaviour of hardened AISI D2 tool steel with different hardness levels

983

Dry sliding friction and wear characteristics of Fe–C–Cu alloy containing molybdenum di sulphide

984

Dry sliding friction and wear properties of Al–25Zn–3Cu–3Si alloy

985

Dry sliding friction and wear properties of Al2O3 and carbon short fibres reinforced Al–12Si alloy hybrid composites

986

Dry sliding friction and wear properties of B4C particulate-reinforced Al-5083 matrix composites

987

Dry sliding friction and wear properties of metallic glass coating and martensite stainless coating

988

Dry sliding friction and wear properties of zinc-based alloys

989

Dry Sliding Friction and Wear Resistance of SnPb-Solder Affected Copper against Stainless Steel Counter Surface

990

Dry sliding of plasma-sintered iron—The influence of nitriding on wear resistance

991

Dry Sliding Oxidative Wear in Plain Carbon Dual Phase Steel Original Research Article

992

Dry sliding tribological behavior and mechanical properties of Al2024–5 wt.%B4C nanocomposite produced by mechanical milling and hot extrusion

993

Dry sliding tribological behavior of AZ31 magnesium alloy irradiated by high-intensity pulsed ion beam

994

Dry sliding tribological behaviors of nanocrystalline Cu–Zn surface layer after annealing in air

995

Dry sliding tribological properties and subsurface structure of nanostructured copper at liquid nitrogen temperature

996

Dry sliding tribological properties of nanostructured copper subjected to dynamic plastic deformation

997

Dry sliding up to 7.5 m/s and 800 °C of thermally sprayed coatings of the TiO2–Cr2O3 system and (Ti,Mo)(C,N)–Ni(Co)

998

Dry sliding wear behavior and corrosion resistance of NiCrBSi coating deposited by activated combustion-high velocity air fuel spray process

999

Dry sliding wear behavior of Al2O3 fiber reinforced aluminum composites

1000

Dry sliding wear behavior of Al-based composites fabricated by exothermic dispersion reaction in an Al–ZrO2–C system

بازگشت